<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00493415</url>
  </required_header>
  <id_info>
    <org_study_id>TPO 436</org_study_id>
    <secondary_id>ABR 12558</secondary_id>
    <secondary_id>Eudract 2006-004298-88</secondary_id>
    <secondary_id>CCMO NL12558.099.06</secondary_id>
    <nct_id>NCT00493415</nct_id>
  </id_info>
  <brief_title>The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis</brief_title>
  <acronym>NISMIS</acronym>
  <official_title>The Evaluation of the Effect of Nitroglycerine Versus Placebo on the Microcirculation by Means of SDF Imaging in Septic Patients on the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Centre Leeuwarden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Centre Leeuwarden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of nitro-glycerine on the
      microcirculation (smallest vessel type) in patients with severe sepsis and septic shock.

      Nitro-glycerine is a well known medicine in cardiology and is used to improve circulation. In
      this ICU the investigators use nitro-glycerine to improve the organ perfusion; but it's no
      common therapy in the rest of the world. The investigators now compare nitro-glycerine and
      placebo by looking to the sublingual microcirculation by a small camera (SDF imaging).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study starts at admission of the patient on the ICU. In the next 24 hours the patient
      receives nitro-glycerine or placebo (randomised). At time = 0, Â½, 2, 12 and 24 hour we
      evaluate the microcirculation by SDF imaging and monitoring of hemodynamic parameters.

      Informed consent is obtained of the relatives.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>increase of MFI by nitro-glycerine</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>decrease of length of stay decrease of SOFA decrease of morbidity/mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>nitroglycerine iv</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>nacl 0.9% 4 ml/h iv in the first 30 minutes, 2 ml/h iv in the next 23 hours and 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nitroglycerin iv</intervention_name>
    <description>loading dose of 4mg/h iv in the first 30 minutes, 2 mg/h iv in the next 23 hours and 30 minutes</description>
    <arm_group_label>1</arm_group_label>
    <other_name>nitropohl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo = nacl 0.9%</intervention_name>
    <description>4 ml/h iv in the first 30 minutes, 2 ml /h iv in the next 23 hours and 30 minutes</description>
    <arm_group_label>2</arm_group_label>
    <other_name>isotonic saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis

          -  Proven infection

          -  Informed consent

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Pregnancy

          -  Use of nitroglycerine within 24 hours prior to ICU admittance

          -  Necessity to use nitroglycerine iv for instable angina
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>E C Boerma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Centre Leeuwarden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Centre Leeuwarden - Intensive Care Unit</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8901 BR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2007</study_first_submitted>
  <study_first_submitted_qc>June 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2007</study_first_posted>
  <last_update_submitted>July 15, 2008</last_update_submitted>
  <last_update_submitted_qc>July 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>EC Boerma</name_title>
    <organization>Medical Center Leeuwarden</organization>
  </responsible_party>
  <keyword>microcirculation</keyword>
  <keyword>sepsis</keyword>
  <keyword>nitroglycerine</keyword>
  <keyword>SDF imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

